Should patients treated with definitive chemoradiation for esophageal cancer receive adjuvant/consolidative immunotherapy?
Answer from: Radiation Oncologist at Academic Institution
A great question – one that we really don’t have data to answer quite yet. Obviously, we do have guidance for resectable patients. CheckMate 577 was a randomized, double-blind, placebo-controlled phase 3 trial in patients with stage II or III esophageal or gastroesophageal cancer who rec...
Sign in or Register to read more